GraphWear, a needle-free continuous glucose monitoring wearable platform, raised $20.5 million in a Series B funding round. Mayfield led the round with participation from MissionBio
GraphWear, a needle-free continuous glucose monitoring wearable platform, raised $20.5 million in a Series B funding round. Mayfield led the round with participation from MissionBio